Healthcare provider profile · identity verified

Fernando Canada

Internal Medicine · MIAMI, FL · NPI 1154331403

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	694	257
Lisinopril	Lisinopril	365	123
Amlodipine Besylate	Amlodipine Besylate	362	132
Losartan Potassium	Losartan Potassium	327	130
Rosuvastatin Calcium	Rosuvastatin Calcium	273	110
Gabapentin	Gabapentin	270	86
Metformin Hcl	Metformin Hcl	256	92
Pantoprazole Sodium	Pantoprazole Sodium	236	90
Tamsulosin Hcl	Tamsulosin Hcl	232	86
Metoprolol Succinate	Metoprolol Succinate	231	82
Hydrochlorothiazide	Hydrochlorothiazide	228	84
Fluticasone Propionate	Fluticasone Propionate	223	79
Levothyroxine Sodium	Levothyroxine Sodium	222	73
Albuterol Sulfate Hfa	Albuterol Sulfate	197	76
Omeprazole	Omeprazole	169	60
Eliquis	Apixaban	167	36
Furosemide	Furosemide	149	56
Famotidine	Famotidine	144	49
Trazodone Hcl	Trazodone Hcl	138	40
Finasteride	Finasteride	128	40
Carvedilol	Carvedilol	117	38
Montelukast Sodium	Montelukast Sodium	102	37
Sertraline Hcl	Sertraline Hcl	93	31
Ketoconazole	Ketoconazole	90	35
Naproxen	Naproxen	87	23
Clopidogrel	Clopidogrel Bisulfate	86	35
Nifedipine Er	Nifedipine	86	27
Metoprolol Tartrate	Metoprolol Tartrate	83	32
Simvastatin	Simvastatin	78	28
Sildenafil Citrate	Sildenafil Citrate	76	22
Ibuprofen	Ibuprofen	72	23
Diclofenac Sodium	Diclofenac Sodium	65	26
Alendronate Sodium	Alendronate Sodium	62	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	62	22
Glimepiride	Glimepiride	62	17
Donepezil Hcl	Donepezil Hcl	60	22
Farxiga	Dapagliflozin Propanediol	57	15
Latanoprost	Latanoprost	57	18
Mirtazapine	Mirtazapine	57	17
Hydralazine Hcl	Hydralazine Hcl	54	16
Memantine Hcl	Memantine Hcl	54	20
Jardiance	Empagliflozin	49	12
Allopurinol	Allopurinol	47	21
Alprazolam	Alprazolam	47	13
Entresto	Sacubitril/Valsartan	47	12
Meclizine Hcl	Meclizine Hcl	46	18
Clobetasol Propionate	Clobetasol Propionate	45	12
Glipizide Er	Glipizide	45	13
Xarelto	Rivaroxaban	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	21
Triamcinolone Acetonide	Triamcinolone Acetonide	39	18
Atenolol	Atenolol	38	11
Wixela Inhub	Fluticasone Propion/Salmeterol	38	suppressed
Glipizide	Glipizide	37	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	13
Vitamin D2	Ergocalciferol (Vitamin D2)	36	18
Sucralfate	Sucralfate	35	suppressed
Tradjenta	Linagliptin	35	suppressed
Ciclopirox	Ciclopirox	34	suppressed
Symbicort	Budesonide/Formoterol Fumarate	34	suppressed
Azithromycin	Azithromycin	33	30
Droplet Pen Needle	Pen Needle, Diabetic	33	12
Ezetimibe	Ezetimibe	31	16
Acyclovir	Acyclovir	30	suppressed
Diltiazem Hcl	Diltiazem Hcl	30	suppressed
Meloxicam	Meloxicam	30	13
Metformin Hcl Er	Metformin Hcl	30	12
Citalopram Hbr	Citalopram Hydrobromide	29	11
Labetalol Hcl	Labetalol Hcl	29	suppressed
Spironolactone	Spironolactone	29	15
Acarbose	Acarbose	27	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	27	27
Azelastine Hcl	Azelastine Hcl	27	11
Myrbetriq	Mirabegron	27	suppressed
Ammonium Lactate	Ammonium Lactate	26	suppressed
Irbesartan	Irbesartan	26	11
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Mupirocin	Mupirocin	25	12
Valsartan	Valsartan	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	11
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	22	22
Chlorthalidone	Chlorthalidone	22	suppressed
Clonazepam	Clonazepam	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Temazepam	Temazepam	22	13
Enalapril Maleate	Enalapril Maleate	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	11
Timolol Maleate	Timolol Maleate	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	13
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Bicalutamide	Bicalutamide	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Methylprednisolone	Methylprednisolone	18	14
Divalproex Sodium	Divalproex Sodium	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Januvia	Sitagliptin Phosphate	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Risperidone	Risperidone	16	suppressed
Ursodiol	Ursodiol	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Repaglinide	Repaglinide	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Cefuroxime	Cefuroxime Axetil	14	11
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Ozempic	Semaglutide	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Methimazole	Methimazole	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Synjardy	Empagliflozin/Metformin Hcl	13	suppressed
Acetazolamide	Acetazolamide	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Brilinta	Ticagrelor	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Baclofen	Baclofen	11	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Combigan	Brimonidine Tartrate/Timolol	11	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error